ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Microneedle Flu Vaccine Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-19R10049
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Microneedle Flu Vaccine Market Insights Forecast to 2028
BUY CHAPTERS

Global Microneedle Flu Vaccine Market Research Report 2025

Code: QYRE-Auto-19R10049
Report
July 2025
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sanofi
GC Pharma
Debiotech
Nanopass Technologies
Corium International
Becton Dickinson and Company
FluGen
CosMED Pharmaceuticals
Microdermics and OraSure Technologies

Microneedle Flu Vaccine Market Size

The global market for Microneedle Flu Vaccine was valued at US$ 1550 million in the year 2024 and is projected to reach a revised size of US$ 2243 million by 2031, growing at a CAGR of 5.5% during the forecast period.

Microneedle Flu Vaccine Market

Microneedle Flu Vaccine Market

Micro-needles are new form of dose delivery systems, which can easily overcome various problems associated with the conventional formulations. Microneedle device consists of needles of micron size, which are arranged on a small dermal patch. The main principle of micro-needles include disruption of the skin layer, thus creating micron size pathway for drug delivery, in which the drugs can easily be transferred from epidermis or upper dermis region directly to the systemic circulation without facing any barrier. Micro-needles are of various types such as dissolving micro-needles, coated micro-needles, hollow micro-needles, and fabricated like solid micro-needles.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Microneedle Flu Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microneedle Flu Vaccine.
The Microneedle Flu Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Microneedle Flu Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Microneedle Flu Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Microneedle Flu Vaccine Market Report

Report Metric Details
Report Name Microneedle Flu Vaccine Market
Accounted market size in year US$ 1550 million
Forecasted market size in 2031 US$ 2243 million
CAGR 5.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Influenza A
  • Influenza B
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sanofi, GC Pharma, Debiotech, NanoPass Technologies, Corium International, Becton Dickinson and Company, FluGen, CosMED Pharmaceuticals, Microdermics and OraSure Technologies
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Microneedle Flu Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Microneedle Flu Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Microneedle Flu Vaccine Market growing?

Ans: The Microneedle Flu Vaccine Market witnessing a CAGR of 5.5% during the forecast period 2025-2031.

What is the Microneedle Flu Vaccine Market size in 2031?

Ans: The Microneedle Flu Vaccine Market size in 2031 will be US$ 2243 million.

Who are the main players in the Microneedle Flu Vaccine Market report?

Ans: The main players in the Microneedle Flu Vaccine Market are Sanofi, GC Pharma, Debiotech, NanoPass Technologies, Corium International, Becton Dickinson and Company, FluGen, CosMED Pharmaceuticals, Microdermics and OraSure Technologies

What are the Application segmentation covered in the Microneedle Flu Vaccine Market report?

Ans: The Applications covered in the Microneedle Flu Vaccine Market report are Influenza A, Influenza B

What are the Type segmentation covered in the Microneedle Flu Vaccine Market report?

Ans: The Types covered in the Microneedle Flu Vaccine Market report are Solid Microneedle, Hollow Microneedle, Coated Microneedle, Dissolving Microneedle

Recommended Reports

Microneedle Technologies

Influenza & Vaccines

Drug Delivery Devices

1 Microneedle Flu Vaccine Market Overview
1.1 Product Definition
1.2 Microneedle Flu Vaccine by Type
1.2.1 Global Microneedle Flu Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Solid Microneedle
1.2.3 Hollow Microneedle
1.2.4 Coated Microneedle
1.2.5 Dissolving Microneedle
1.3 Microneedle Flu Vaccine by Application
1.3.1 Global Microneedle Flu Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Influenza A
1.3.3 Influenza B
1.4 Global Microneedle Flu Vaccine Market Size Estimates and Forecasts
1.4.1 Global Microneedle Flu Vaccine Revenue 2020-2031
1.4.2 Global Microneedle Flu Vaccine Sales 2020-2031
1.4.3 Global Microneedle Flu Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Microneedle Flu Vaccine Market Competition by Manufacturers
2.1 Global Microneedle Flu Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Microneedle Flu Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Microneedle Flu Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Microneedle Flu Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Microneedle Flu Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Microneedle Flu Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Microneedle Flu Vaccine, Date of Enter into This Industry
2.8 Global Microneedle Flu Vaccine Market Competitive Situation and Trends
2.8.1 Global Microneedle Flu Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Microneedle Flu Vaccine Players Market Share by Revenue
2.8.3 Global Microneedle Flu Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Microneedle Flu Vaccine Market Scenario by Region
3.1 Global Microneedle Flu Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Microneedle Flu Vaccine Sales by Region: 2020-2031
3.2.1 Global Microneedle Flu Vaccine Sales by Region: 2020-2025
3.2.2 Global Microneedle Flu Vaccine Sales by Region: 2026-2031
3.3 Global Microneedle Flu Vaccine Revenue by Region: 2020-2031
3.3.1 Global Microneedle Flu Vaccine Revenue by Region: 2020-2025
3.3.2 Global Microneedle Flu Vaccine Revenue by Region: 2026-2031
3.4 North America Microneedle Flu Vaccine Market Facts & Figures by Country
3.4.1 North America Microneedle Flu Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Microneedle Flu Vaccine Sales by Country (2020-2031)
3.4.3 North America Microneedle Flu Vaccine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Microneedle Flu Vaccine Market Facts & Figures by Country
3.5.1 Europe Microneedle Flu Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Microneedle Flu Vaccine Sales by Country (2020-2031)
3.5.3 Europe Microneedle Flu Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Microneedle Flu Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Microneedle Flu Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Microneedle Flu Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Microneedle Flu Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Microneedle Flu Vaccine Market Facts & Figures by Country
3.7.1 Latin America Microneedle Flu Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Microneedle Flu Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Microneedle Flu Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Microneedle Flu Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Microneedle Flu Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Microneedle Flu Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Microneedle Flu Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Microneedle Flu Vaccine Sales by Type (2020-2031)
4.1.1 Global Microneedle Flu Vaccine Sales by Type (2020-2025)
4.1.2 Global Microneedle Flu Vaccine Sales by Type (2026-2031)
4.1.3 Global Microneedle Flu Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Microneedle Flu Vaccine Revenue by Type (2020-2031)
4.2.1 Global Microneedle Flu Vaccine Revenue by Type (2020-2025)
4.2.2 Global Microneedle Flu Vaccine Revenue by Type (2026-2031)
4.2.3 Global Microneedle Flu Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Microneedle Flu Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Microneedle Flu Vaccine Sales by Application (2020-2031)
5.1.1 Global Microneedle Flu Vaccine Sales by Application (2020-2025)
5.1.2 Global Microneedle Flu Vaccine Sales by Application (2026-2031)
5.1.3 Global Microneedle Flu Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Microneedle Flu Vaccine Revenue by Application (2020-2031)
5.2.1 Global Microneedle Flu Vaccine Revenue by Application (2020-2025)
5.2.2 Global Microneedle Flu Vaccine Revenue by Application (2026-2031)
5.2.3 Global Microneedle Flu Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Microneedle Flu Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Company Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sanofi Microneedle Flu Vaccine Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 GC Pharma
6.2.1 GC Pharma Company Information
6.2.2 GC Pharma Description and Business Overview
6.2.3 GC Pharma Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 GC Pharma Microneedle Flu Vaccine Product Portfolio
6.2.5 GC Pharma Recent Developments/Updates
6.3 Debiotech
6.3.1 Debiotech Company Information
6.3.2 Debiotech Description and Business Overview
6.3.3 Debiotech Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Debiotech Microneedle Flu Vaccine Product Portfolio
6.3.5 Debiotech Recent Developments/Updates
6.4 NanoPass Technologies
6.4.1 NanoPass Technologies Company Information
6.4.2 NanoPass Technologies Description and Business Overview
6.4.3 NanoPass Technologies Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 NanoPass Technologies Microneedle Flu Vaccine Product Portfolio
6.4.5 NanoPass Technologies Recent Developments/Updates
6.5 Corium International
6.5.1 Corium International Company Information
6.5.2 Corium International Description and Business Overview
6.5.3 Corium International Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Corium International Microneedle Flu Vaccine Product Portfolio
6.5.5 Corium International Recent Developments/Updates
6.6 Becton Dickinson and Company
6.6.1 Becton Dickinson and Company Company Information
6.6.2 Becton Dickinson and Company Description and Business Overview
6.6.3 Becton Dickinson and Company Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Becton Dickinson and Company Microneedle Flu Vaccine Product Portfolio
6.6.5 Becton Dickinson and Company Recent Developments/Updates
6.7 FluGen
6.7.1 FluGen Company Information
6.7.2 FluGen Description and Business Overview
6.7.3 FluGen Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 FluGen Microneedle Flu Vaccine Product Portfolio
6.7.5 FluGen Recent Developments/Updates
6.8 CosMED Pharmaceuticals
6.8.1 CosMED Pharmaceuticals Company Information
6.8.2 CosMED Pharmaceuticals Description and Business Overview
6.8.3 CosMED Pharmaceuticals Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 CosMED Pharmaceuticals Microneedle Flu Vaccine Product Portfolio
6.8.5 CosMED Pharmaceuticals Recent Developments/Updates
6.9 Microdermics and OraSure Technologies
6.9.1 Microdermics and OraSure Technologies Company Information
6.9.2 Microdermics and OraSure Technologies Description and Business Overview
6.9.3 Microdermics and OraSure Technologies Microneedle Flu Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Microdermics and OraSure Technologies Microneedle Flu Vaccine Product Portfolio
6.9.5 Microdermics and OraSure Technologies Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Microneedle Flu Vaccine Industry Chain Analysis
7.2 Microneedle Flu Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Microneedle Flu Vaccine Production Mode & Process Analysis
7.4 Microneedle Flu Vaccine Sales and Marketing
7.4.1 Microneedle Flu Vaccine Sales Channels
7.4.2 Microneedle Flu Vaccine Distributors
7.5 Microneedle Flu Vaccine Customer Analysis
8 Microneedle Flu Vaccine Market Dynamics
8.1 Microneedle Flu Vaccine Industry Trends
8.2 Microneedle Flu Vaccine Market Drivers
8.3 Microneedle Flu Vaccine Market Challenges
8.4 Microneedle Flu Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Sanofi
GC Pharma
Debiotech
Nanopass Technologies
Corium International
Becton Dickinson and Company
FluGen
CosMED Pharmaceuticals
Microdermics and OraSure Technologies
List of Tables
 Table 1. Global Microneedle Flu Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Microneedle Flu Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Microneedle Flu Vaccine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Microneedle Flu Vaccine Sales (K Dose) of Key Manufacturers (2020-2025)
 Table 5. Global Microneedle Flu Vaccine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Microneedle Flu Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Microneedle Flu Vaccine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Microneedle Flu Vaccine Average Price (US$/Dose) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Microneedle Flu Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Microneedle Flu Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Microneedle Flu Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of Microneedle Flu Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Microneedle Flu Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microneedle Flu Vaccine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Microneedle Flu Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Microneedle Flu Vaccine Sales by Region (2020-2025) & (K Dose)
 Table 18. Global Microneedle Flu Vaccine Sales Market Share by Region (2020-2025)
 Table 19. Global Microneedle Flu Vaccine Sales by Region (2026-2031) & (K Dose)
 Table 20. Global Microneedle Flu Vaccine Sales Market Share by Region (2026-2031)
 Table 21. Global Microneedle Flu Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Microneedle Flu Vaccine Revenue Market Share by Region (2020-2025)
 Table 23. Global Microneedle Flu Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Microneedle Flu Vaccine Revenue Market Share by Region (2026-2031)
 Table 25. North America Microneedle Flu Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Microneedle Flu Vaccine Sales by Country (2020-2025) & (K Dose)
 Table 27. North America Microneedle Flu Vaccine Sales by Country (2026-2031) & (K Dose)
 Table 28. North America Microneedle Flu Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Microneedle Flu Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Microneedle Flu Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Microneedle Flu Vaccine Sales by Country (2020-2025) & (K Dose)
 Table 32. Europe Microneedle Flu Vaccine Sales by Country (2026-2031) & (K Dose)
 Table 33. Europe Microneedle Flu Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Microneedle Flu Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Microneedle Flu Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Microneedle Flu Vaccine Sales by Region (2020-2025) & (K Dose)
 Table 37. Asia Pacific Microneedle Flu Vaccine Sales by Region (2026-2031) & (K Dose)
 Table 38. Asia Pacific Microneedle Flu Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Microneedle Flu Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Microneedle Flu Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Microneedle Flu Vaccine Sales by Country (2020-2025) & (K Dose)
 Table 42. Latin America Microneedle Flu Vaccine Sales by Country (2026-2031) & (K Dose)
 Table 43. Latin America Microneedle Flu Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Microneedle Flu Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Microneedle Flu Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Microneedle Flu Vaccine Sales by Country (2020-2025) & (K Dose)
 Table 47. Middle East and Africa Microneedle Flu Vaccine Sales by Country (2026-2031) & (K Dose)
 Table 48. Middle East and Africa Microneedle Flu Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Microneedle Flu Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Microneedle Flu Vaccine Sales (K Dose) by Type (2020-2025)
 Table 51. Global Microneedle Flu Vaccine Sales (K Dose) by Type (2026-2031)
 Table 52. Global Microneedle Flu Vaccine Sales Market Share by Type (2020-2025)
 Table 53. Global Microneedle Flu Vaccine Sales Market Share by Type (2026-2031)
 Table 54. Global Microneedle Flu Vaccine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Microneedle Flu Vaccine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Microneedle Flu Vaccine Revenue Market Share by Type (2020-2025)
 Table 57. Global Microneedle Flu Vaccine Revenue Market Share by Type (2026-2031)
 Table 58. Global Microneedle Flu Vaccine Price (US$/Dose) by Type (2020-2025)
 Table 59. Global Microneedle Flu Vaccine Price (US$/Dose) by Type (2026-2031)
 Table 60. Global Microneedle Flu Vaccine Sales (K Dose) by Application (2020-2025)
 Table 61. Global Microneedle Flu Vaccine Sales (K Dose) by Application (2026-2031)
 Table 62. Global Microneedle Flu Vaccine Sales Market Share by Application (2020-2025)
 Table 63. Global Microneedle Flu Vaccine Sales Market Share by Application (2026-2031)
 Table 64. Global Microneedle Flu Vaccine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Microneedle Flu Vaccine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Microneedle Flu Vaccine Revenue Market Share by Application (2020-2025)
 Table 67. Global Microneedle Flu Vaccine Revenue Market Share by Application (2026-2031)
 Table 68. Global Microneedle Flu Vaccine Price (US$/Dose) by Application (2020-2025)
 Table 69. Global Microneedle Flu Vaccine Price (US$/Dose) by Application (2026-2031)
 Table 70. Sanofi Company Information
 Table 71. Sanofi Description and Business Overview
 Table 72. Sanofi Microneedle Flu Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 73. Sanofi Microneedle Flu Vaccine Product
 Table 74. Sanofi Recent Developments/Updates
 Table 75. GC Pharma Company Information
 Table 76. GC Pharma Description and Business Overview
 Table 77. GC Pharma Microneedle Flu Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 78. GC Pharma Microneedle Flu Vaccine Product
 Table 79. GC Pharma Recent Developments/Updates
 Table 80. Debiotech Company Information
 Table 81. Debiotech Description and Business Overview
 Table 82. Debiotech Microneedle Flu Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 83. Debiotech Microneedle Flu Vaccine Product
 Table 84. Debiotech Recent Developments/Updates
 Table 85. NanoPass Technologies Company Information
 Table 86. NanoPass Technologies Description and Business Overview
 Table 87. NanoPass Technologies Microneedle Flu Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 88. NanoPass Technologies Microneedle Flu Vaccine Product
 Table 89. NanoPass Technologies Recent Developments/Updates
 Table 90. Corium International Company Information
 Table 91. Corium International Description and Business Overview
 Table 92. Corium International Microneedle Flu Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 93. Corium International Microneedle Flu Vaccine Product
 Table 94. Corium International Recent Developments/Updates
 Table 95. Becton Dickinson and Company Company Information
 Table 96. Becton Dickinson and Company Description and Business Overview
 Table 97. Becton Dickinson and Company Microneedle Flu Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 98. Becton Dickinson and Company Microneedle Flu Vaccine Product
 Table 99. Becton Dickinson and Company Recent Developments/Updates
 Table 100. FluGen Company Information
 Table 101. FluGen Description and Business Overview
 Table 102. FluGen Microneedle Flu Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 103. FluGen Microneedle Flu Vaccine Product
 Table 104. FluGen Recent Developments/Updates
 Table 105. CosMED Pharmaceuticals Company Information
 Table 106. CosMED Pharmaceuticals Description and Business Overview
 Table 107. CosMED Pharmaceuticals Microneedle Flu Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 108. CosMED Pharmaceuticals Microneedle Flu Vaccine Product
 Table 109. CosMED Pharmaceuticals Recent Developments/Updates
 Table 110. Microdermics and OraSure Technologies Company Information
 Table 111. Microdermics and OraSure Technologies Description and Business Overview
 Table 112. Microdermics and OraSure Technologies Microneedle Flu Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 113. Microdermics and OraSure Technologies Microneedle Flu Vaccine Product
 Table 114. Microdermics and OraSure Technologies Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Microneedle Flu Vaccine Distributors List
 Table 118. Microneedle Flu Vaccine Customers List
 Table 119. Microneedle Flu Vaccine Market Trends
 Table 120. Microneedle Flu Vaccine Market Drivers
 Table 121. Microneedle Flu Vaccine Market Challenges
 Table 122. Microneedle Flu Vaccine Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Microneedle Flu Vaccine
 Figure 2. Global Microneedle Flu Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Microneedle Flu Vaccine Market Share by Type: 2024 & 2031
 Figure 4. Solid Microneedle Product Picture
 Figure 5. Hollow Microneedle Product Picture
 Figure 6. Coated Microneedle Product Picture
 Figure 7. Dissolving Microneedle Product Picture
 Figure 8. Global Microneedle Flu Vaccine Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Microneedle Flu Vaccine Market Share by Application: 2024 & 2031
 Figure 10. Influenza A
 Figure 11. Influenza B
 Figure 12. Global Microneedle Flu Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Microneedle Flu Vaccine Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Microneedle Flu Vaccine Sales (2020-2031) & (K Dose)
 Figure 15. Global Microneedle Flu Vaccine Average Price (US$/Dose) & (2020-2031)
 Figure 16. Microneedle Flu Vaccine Report Years Considered
 Figure 17. Microneedle Flu Vaccine Sales Share by Manufacturers in 2024
 Figure 18. Global Microneedle Flu Vaccine Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Microneedle Flu Vaccine Players: Market Share by Revenue in Microneedle Flu Vaccine in 2024
 Figure 20. Microneedle Flu Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Microneedle Flu Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Microneedle Flu Vaccine Sales Market Share by Country (2020-2031)
 Figure 23. North America Microneedle Flu Vaccine Revenue Market Share by Country (2020-2031)
 Figure 24. United States Microneedle Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Microneedle Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Microneedle Flu Vaccine Sales Market Share by Country (2020-2031)
 Figure 27. Europe Microneedle Flu Vaccine Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Microneedle Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Microneedle Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Microneedle Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Microneedle Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Microneedle Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Microneedle Flu Vaccine Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Microneedle Flu Vaccine Revenue Market Share by Region (2020-2031)
 Figure 35. China Microneedle Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Microneedle Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Microneedle Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Microneedle Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Microneedle Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Microneedle Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Microneedle Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Microneedle Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Microneedle Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Microneedle Flu Vaccine Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Microneedle Flu Vaccine Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Microneedle Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Microneedle Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Microneedle Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Microneedle Flu Vaccine Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Microneedle Flu Vaccine Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Microneedle Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Microneedle Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Microneedle Flu Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Microneedle Flu Vaccine by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Microneedle Flu Vaccine by Type (2020-2031)
 Figure 56. Global Microneedle Flu Vaccine Price (US$/Dose) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Microneedle Flu Vaccine by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Microneedle Flu Vaccine by Application (2020-2031)
 Figure 59. Global Microneedle Flu Vaccine Price (US$/Dose) by Application (2020-2031)
 Figure 60. Microneedle Flu Vaccine Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Vaccine Microneedle Patches Market Research Report 2024
Global Drug Microneedle Patches Market Research Report 2024
Microneedle Drug Delivery Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Microneedle based Drug Delivery System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Microneedle Patch Transdermal Drug Delivery Systems Market Research Report 2025
Global Hollow Microneedle Technology Market Research Report 2024
Global Portable Microneedle Machine Market Research Report 2024
Global Dissolvable Microneedle Transdermal Drug Delivery Technology Market Research Report 2024
Global Microneedle Skincare Patches Market Research Report 2024
Global Cosmetic Painless Microneedle Transdermal Patch Market Research Report 2024
Global Soluble Microneedle Market Research Report 2025
Global Dissolvable Microneedle Patches Market Research Report 2024
Global Microneedling Devices Market Research Report 2024
Global Microneedle Eye Patch Market Research Report 2025
Biodegradable Microneedle Patch Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Intradermal Needle free Vaccination Device Market Research Report 2025
Global Soluble Microneedle Patches Market Research Report 2025
Global Body RF Microneedling Market Research Report 2025
Global Dissolving Microneedle Patch for Cosmetics Market Research Report 2025
Global Microneedling Cartridges Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions